Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Palmitoylethanolamide and Cannabidiol Prevent Inflammation-induced Hyperpermeability of the Human Gut In Vitro and In Vivo—A Randomized, Placebo-controlled, Double-blind Controlled Trial
D. G. Couch, Hollie Cook, Catherine A. Ortori, et al.
Inflammatory Bowel Diseases (2019) Vol. 25, Iss. 6, pp. 1006-1018
Open Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

Cannabidiol: pharmacology and therapeutic targets
Stevie C. Britch, Shanna Babalonis, Sharon Walsh
Psychopharmacology (2020) Vol. 238, Iss. 1, pp. 9-28
Open Access | Times Cited: 221
A randomized, double-blind, placebo-controlled study of daily cannabidiol for the treatment of canine osteoarthritis pain
Christopher D. Verrico, Shonda Wesson, Vanaja Konduri, et al.
Pain (2020) Vol. 161, Iss. 9, pp. 2191-2202
Open Access | Times Cited: 147
Role of prebiotics, probiotics, and synbiotics in management of inflammatory bowel disease: Current perspectives
Supriya Roy, Suneela Dhaneshwar
World Journal of Gastroenterology (2023) Vol. 29, Iss. 14, pp. 2078-2100
Open Access | Times Cited: 136
An Overview of Cannabidiol as a Multifunctional Drug: Pharmacokinetics and Cellular Effects
Nadia Martínez Naya, Jazmin Kelly, Giuliana Corna, et al.
Molecules (2024) Vol. 29, Iss. 2, pp. 473-473
Open Access | Times Cited: 22
Cannabis sativa: Much more beyond Δ9-tetrahydrocannabinol
Patrícia Alves, Cristina Amaral, Natércia Teixeira, et al.
Pharmacological Research (2020) Vol. 157, pp. 104822-104822
Closed Access | Times Cited: 106
Cannabis, the Endocannabinoid System and Immunity—the Journey from the Bedside to the Bench and Back
Osnat Almogi‐Hazan, Reuven Or
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4448-4448
Open Access | Times Cited: 101
Next-Generation Probiotics for Inflammatory Bowel Disease
Marcella Pesce, Luisa Seguella, Alessandro Re, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5466-5466
Open Access | Times Cited: 42
The therapeutic potential of purified cannabidiol
Saoirse E. O’Sullivan, Sanne Jensen, Gitte Nykjaer Nikolajsen, et al.
Journal of Cannabis Research (2023) Vol. 5, Iss. 1
Open Access | Times Cited: 29
Cannabinoids in Medicine: A Multifaceted Exploration of Types, Therapeutic Applications, and Emerging Opportunities in Neurodegenerative Diseases and Cancer Therapy
Victor Voicu, Felix-Mircea Brehar, Corneliu Toader, et al.
Biomolecules (2023) Vol. 13, Iss. 9, pp. 1388-1388
Open Access | Times Cited: 28
The Use of Cannabinoids in the Treatment of Inflammatory Bowel Disease (IBD): A Review of the Literature
Basil N Nduma, Kelly A Mofor, Jason Tatang, et al.
Cureus (2023)
Open Access | Times Cited: 25
Palmitoylethanolamide counteracts high-fat diet-induced gut dysfunction by reprogramming microbiota composition and affecting tryptophan metabolism
Claudio Pirozzi, Lorena Coretti, Nicola Opallo, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 22
The NLRP3 inflammasome: a vital player in inflammation and mediating the anti-inflammatory effect of CBD
Feng-xin Chu, Xiao Wang, Bo Li, et al.
Inflammation Research (2024) Vol. 73, Iss. 2, pp. 227-242
Closed Access | Times Cited: 12
Palmitoylethanolamide and polydatin in pediatric irritable bowel syndrome: A multicentric randomized controlled trial
Giovanni Di Nardo, Luca Bernardo, Cesare Cremon, et al.
Nutrition (2024) Vol. 122, pp. 112397-112397
Open Access | Times Cited: 9
Pharmacological Treatment of Fibromyalgia Syndrome: A Practice-Based Review
Valeria Giorgi, Piercarlo Sarzi‐Puttini, Greta Pellegrino, et al.
Current Pain and Headache Reports (2024)
Open Access | Times Cited: 8
Caco2/HT-29 In Vitro Cell Co-Culture: Barrier Integrity, Permeability, and Tight Junctions’ Composition During Progressive Passages of Parental Cells
Elena Donetti, Paola Bendinelli, Margherita Correnti, et al.
Biology (2025) Vol. 14, Iss. 3, pp. 267-267
Open Access | Times Cited: 1
Cannabinoids and Opioids in the Treatment of Inflammatory Bowel Diseases
Melanie Kienzl, Martin Storr, Rudolf Schicho
Clinical and Translational Gastroenterology (2020) Vol. 11, Iss. 1, pp. e00120-e00120
Open Access | Times Cited: 54
Cannabinoids and Inflammations of the Gut-Lung-Skin Barrier
Cristian Scheau, Constantin Căruntu, Ioana Anca Bădărău, et al.
Journal of Personalized Medicine (2021) Vol. 11, Iss. 6, pp. 494-494
Open Access | Times Cited: 49
Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
Barbara Malinowska, Marta Baranowska‐Kuczko, Aleksandra Kicman, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 4, pp. 1986-1986
Open Access | Times Cited: 46
Endocannabinoid system mediates the association between gut-microbial diversity and anhedonia/amotivation in a general population cohort
Amedeo Minichino, Matthew Jackson, Marta Francesconi, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 11, pp. 6269-6276
Open Access | Times Cited: 43
GPR119 and GPR55 as Receptors for Fatty Acid Ethanolamides, Oleoylethanolamide and Palmitoylethanolamide
Dong‐Soon Im
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 3, pp. 1034-1034
Open Access | Times Cited: 42
Remodeling of microbiota gut-brain axis using psychobiotics in depression
Mani Surya Kumar Palepu, Manoj P. Dandekar
European Journal of Pharmacology (2022) Vol. 931, pp. 175171-175171
Closed Access | Times Cited: 32
Anti-Microbial Activity of Phytocannabinoids and Endocannabinoids in the Light of Their Physiological and Pathophysiological Roles
Ronit Vogt Sionov, Doron Steinberg
Biomedicines (2022) Vol. 10, Iss. 3, pp. 631-631
Open Access | Times Cited: 28
Beyond Pain Relief: A Review on Cannabidiol Potential in Medical Therapies
Mariana Veiga, João Azevedo‐Silva, João Carlos Fernandes
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 155-155
Open Access | Times Cited: 17
Dietary Cannabidiol Activates PKA/AMPK Signaling and Attenuates Chronic Inflammation and Leaky Gut in DSS‐Induced Colitis Mice
Qi Sun, Alejandro Bravo Iniguez, Qiyu Tian, et al.
Molecular Nutrition & Food Research (2024) Vol. 68, Iss. 4
Open Access | Times Cited: 6
CBD and THC in Special Populations: Pharmacokinetics and Drug–Drug Interactions
Lixuan Qian, Jessica L. Beers, Klarissa D. Jackson, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 484-484
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top